G01N 2333/645
Secretins
G01N2333/645 (Secretins) appears on 9 US grants and 11 published applications in this corpus.
Search patents in G01N- Granted patents
- 9
- Published applications
- 11
- Assignees
- 7
- Inventors
- 20
- Latest grant
- 10 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 2 |
| 2009 | 0 | 0 |
| 2010 | 2 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Method of glucose-dependent insulinotropic polypeptide (GIP) stabilization10 Dec 2024US 12,163,966 B2Mars, Incorporated
- Method26 Nov 2019US 10,488,423 B2Mars, Incorporated
- Screening methods using G-protein coupled receptors and related compositions16 Jun 2015US 9,057,727 B2Chugai Pharmaceutical Co., Ltd.
- Screening methods using G-protein coupled receptors and related compositions29 Oct 2013US 8,568,737 B2Chugai Pharmaceutical Co., Ltd.
- Methods and reagents for treating glucose metabolic disorders5 Oct 2010US 7,807,641 B2Curis, Inc.
- Method of glucose-dependent insulinotropic polypeptide (gip) stabilization24 Apr 2025US 2025/0130247 A1Mars, Incorporated
- Method23 Apr 2020US 2020/0124621 A1Mars, Incorporated
- Method22 Jun 2017US 2017/0176466 A1Mars, Incorporated
- Screening methods using g-protein coupled receptors and related compositions27 Mar 2014US 2014/0086842 A1Chugai Pharmaceutical Co., Ltd.
- Screening methods using g-protein coupled receptors and related compositions14 Jul 2011US 2011/0172153 A1Chugai Pharmaceutical Co., Ltd.
Most cited
By later US patents
- Method for assisting in differential diagnosis and treatment of autistic syndromes82US 6,020,310 ARepligen Corporation · 2000
- Method for assisting in differential diagnosis and treatment of autistic syndromes64US 6,498,143 B1Repligen Corporation · 2002
- Method for assisting in differential diagnosis and treatment of autistic syndromes59US 7,091,182 B2Repligen Corporation · 2006
- Methods and reagents for treating glucose metabolic disorders14US 7,745,216 B2Curis, Inc. · 2010
- Methods and reagents for treating glucose metabolic disorders12US 7,807,641 B2Curis, Inc. · 2010